一个患有脊髓炎的病例,该病例发生在接受JAK抑制剂治疗的患者身上,该患者患有风湿性关节炎
Tomomichi Shimizu1, Ayako Hirota, Nobuhiro Takahashi
1Department of Dermatology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. shimizu.t@tokai.ac.jp.
The Tokai journal of experimental and clinical medicine
|August 25, 2024
概括
一名接受巴里西提尼布治疗的患者患有结核病 (Mycobacterium tuberculosis),表现为皮下和淋巴腺病. 迅速的抗结核治疗导致了完全的解决,突出了JAK抑制剂治疗的罕见但严重的不良事件.
科学领域:
- 类风湿病学 类风湿病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 巴里西提尼布是一种用于类风湿性关节炎的Janus激酶 (JAK) 抑制剂.
- 来自JAK抑制剂的免疫抑制可以增加机会性感染的风险,包括结核病.
研究的目的:
- 在接受巴里西提尼布治疗的患者中报告结核病例 (结核性皮肤病和结核性淋巴腺炎).
- 强调在接受JAK抑制剂的患者中对结核病的警的重要性.
主要方法:
- 一名78岁的女性患有类风湿性关节炎,接受巴里西提尼布治疗,出现皮下.
- 诊断工作包括对比度增强的CT扫描和腹和皮肤活检的培养.
- 治疗包括标准的6个月抗结核疗法.
主要成果:
- 培养物证实了Mycobacterium结核病菌感染,导致诊断为皮病和结核性淋巴腺炎.
- 患者对抗结核治疗反应良好,和淋巴腺病在6个月后完全消失.
- 在随访期间没有发现复发.
结论:
- 结核病是一种罕见但严重的不良事件,与巴里西替尼 (JAK抑制剂) 治疗有关.
- 在这种情况下,早期诊断和适当的抗结核治疗对于有利的结果至关重要.
- 临床医生应在接受JAK抑制剂并出现相关症状的患者中保持对结核病的高度怀疑指数.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Skin Diseases and Disorders
3.7K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.7K


